Exciting Updates on the GluCurve Pet CGM Launch
ALR Technologies SG Ltd (OTC: ALRTF), a leader in diabetes management, is gearing up to relaunch its pioneering GluCurve Pet CGM. This innovative product is designed specifically for monitoring diabetic pets, offering pet owners a reliable way to care for their furry friends. After extensive internal testing and improvements, the GluCurve Pet CGM is ready to hit the market in January 2026, following a successful round of manufacturing trials.
What is GluCurve Pet CGM?
The GluCurve Pet CGM is the first continuous glucose monitor tailored for veterinary use. Unlike traditional methods that require painful blood draws, the GluCurve employs a sensor that can be easily attached to cats and dogs, providing continuous blood sugar readings every three minutes for up to 14 days. Pet owners can conveniently track their pets' blood sugar levels via the associated GluCurve Pet CGM app. Data is also sent to the ALRT Veterinary Web Portal, allowing vets to remotely manage insulin dosing more accurately.
Market Potential and Demand
Joe Stern, the Head of Animal Health at ALRT, highlighted the significant market opportunity for the GluCurve Pet CGM. Current estimates project that in Canada alone, the demand could reach between 150,000 to 300,000 units annually. In the United States, this number jumps to between 2 million and 3 million units each year, with Europe showcasing similar potential. The unique need for a painless method to monitor blood sugar levels in pets has generated considerable interest from veterinarians and pet owners alike.
Partnerships and Collaborations
ALRT is thrilled to collaborate with CGM Medical Technology Shenzhen Ltd. on manufacturing the GluCurve units. Together, they have spent two years enhancing manufacturing capabilities at the Foxconn facility in Shenzhen, preparing for this significant product launch. A vital component of the relaunch strategy includes integrating feedback from veterinarians and enhancing the overall efficiency of the monitoring system.
Independent Studies to Validate Efficacy
In addition to internal testing, an independent non-inferiority study of the GluCurve Pet CGM is scheduled for mid-December. This study will evaluate the device's efficacy against leading veterinary blood glucose meters, which are considered the gold standard in pet diabetes management. The results of this study will be crucial to ensuring that the GluCurve meets the expectations set by both pet owners and veterinary professionals.
Direct Access for Veterinary Clinics
Upon the relaunch, veterinary clinics across Canada will have the option to order the GluCurve Pet CGM directly from the official website. In addition to direct sales, ALRT is forming partnerships with purchasing groups and corporations to facilitate wider access to this essential tool for diabetes management in pets.
Plans for Future Launches
The United States is set for its own relaunch of the GluCurve Pet CGM in early Q2 2026, in collaboration with a leading veterinary distributor. Following success in North America, ALRT is eager to expand globally, targeting markets in Europe, Australia, Asia, and South America. This strategic rollout will ensure that more pet owners gain access to this innovative diabetes monitoring solution.
About ALR Technologies SG Ltd.
ALR Technologies SG Ltd. is known for its comprehensive approaches to diabetes management. Their flagship product, the ALRT Diabetes Solution, is designed to help people with diabetes track glucose levels effectively and optimize their treatment. The company's animal health division aims to extend similar benefits to pets through the GluCurve Pet CGM, providing veterinarians with crucial data to inform insulin treatment decisions.
Contact Information
For further inquiries, please reach out to the investor relations team or animal health inquiries directly. ALRT is committed to transparency and providing updates as they prepare for this exciting relaunch. Reach out via their website for the latest news and product availability.
Frequently Asked Questions
What is the GluCurve Pet CGM?
The GluCurve Pet CGM is a continuous glucose monitor designed for pets, providing accurate blood sugar readings without painful blood draws.
When is the GluCurve Pet CGM being relaunched?
The relaunch is set for January 2026 in Canada, with subsequent launches planned for the U.S. and global markets.
How does the GluCurve Pet CGM benefit pet owners?
It allows pet owners to monitor their pet's blood sugar levels easily, ensuring timely adjustments to insulin treatment.
What partnerships does ALRT have for the manufacturing of GluCurve?
ALRT collaborates with CGM Medical Technology Shenzhen Ltd. to manufacture GluCurve units effectively and efficiently.
Why is this launch important?
This launch offers an innovative solution for managing diabetic pets, fulfilling a critical need in veterinary healthcare.
